Engaging stakeholders at oncology accounts is becoming increasingly more complex as the market continues to evolve and grow.
PULSE Analytics has the data you need to pave the way to market access success.
With PULSE Analytics, you can:
- Be more proactive and responsive to emerging specialty market access needs
- Optimize targeting and resourcing through the lens of value and quality
- Support strategic engagement planning to enhance pull-through
PULSE Analytics is one of the most comprehensive and granular data sets to help pharma companies get the actionable insights they need to target critical accounts, with:
90
Providers
9,000
Oncologists
89 million
payer medical lives
75+
organizations
2,000+
key decision makers
150 brands
for each pathway
PULSE data modules give you insights on:
- Clinical Pathways: Evaluate clinical pathways adoption by payers and providers, implementation sophistication, financial incentives/penalties and brand-specific access risks or opportunities.
- Payer Quality of Access: Evaluate coverage restrictions down to a specific indication and line of therapy, plus regional coverage targets and competitive access, to determine coverage threats & opportunities for targeted planning.
- Provider Key Accounts: Establish understanding of high-impact key accounts through assessment of indication-specific clinical, operational and economic behavior & trends to optimize targeted engagement strategies and operationalize tactical planning approaches.
- Key Decision Makers: Discover relevant clinical & non-clinical key decision-makers in oncology across specialties, accounts, networks, and geographies, while gaining insight into their broader spheres of influence, to optimize targeted engagement strategies.
- Net Cost Recovery: Explore provider channel economics, including reimbursement trends, net cost recovery dynamics, and impact on account behavior to inform channel strategy.
- Alternative Payment Models: Evaluate and monitor the landscape of oncology value-based reimbursement models, including provider/payer participants, program structures, implementation requirements, and other value drivers to understand their impact on patient care.
- Medical Benefit Management: Profile medical benefit manager (oncology, lab, radiopharmaceutical) payer partnerships & understand the payer and provider market access impact of MBMs on your target brands.
- Distribution Analog Launch Planning: Evaluate analog distribution and dispensing trends to inform model design and channel strategy based on product and indication-specific characteristics.
- VA Oncology Access: Visualize & track VA oncology access to support engagement efforts across national and site-level VA stakeholders.
Ready to get started? Request a demo.
